Byler Timothy K, Bratslavsky Gennady
Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
World J Urol. 2014 Jun;32(3):623-30. doi: 10.1007/s00345-014-1287-4. Epub 2014 Apr 8.
Hereditary renal cancer syndromes have been described and have illuminated novel methods to treat sporadic renal cell carcinoma. In this work, we aimed to review the genetic basis, molecular pathology and clinical manifestations of hereditary syndromes, as well as outline principles of surgical management and use of targeted therapy.
We performed a comprehensive review of selected peer-reviewed publications regarding hereditary renal cancer syndromes, their genetic basis, and recommendations for surgical management.
The major syndromes contributing to hereditary renal cell carcinoma are discussed along with relevant literature guiding their management. The evolving surgical and molecular treatments are discussed.
Identification of genetic basis of hereditary carcinomas provides opportunity for targeted therapy of metastatic sporadic renal cell carcinoma. Appropriate and timely surgical management of hereditary renal cancers decreases the possibility of development of metastatic disease, and allows for preservation of renal function despite the need for repeat surgical interventions.
遗传性肾癌综合征已被描述,并为治疗散发性肾细胞癌提供了新方法。在本研究中,我们旨在综述遗传性综合征的遗传基础、分子病理学和临床表现,以及概述手术管理原则和靶向治疗的应用。
我们对有关遗传性肾癌综合征、其遗传基础以及手术管理建议的精选同行评审出版物进行了全面综述。
讨论了导致遗传性肾细胞癌的主要综合征以及指导其管理的相关文献。还讨论了不断发展的手术和分子治疗方法。
确定遗传性癌的遗传基础为转移性散发性肾细胞癌的靶向治疗提供了机会。对遗传性肾癌进行适当及时的手术管理可降低转移性疾病发生的可能性,并且尽管需要重复手术干预,但仍能保留肾功能。